Skip to main content
OpenTrials

Clinical trial condition

Inflammatory Bowel Diseases

Explore clinical trials studying Inflammatory Bowel Diseases. Study availability and eligibility vary by location and protocol.

1,523 public trials 288 recruiting studies
Refine in advanced search Browse all conditions

Inflammatory Bowel Diseases trial results

Completed

Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis

NCT02435992

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • Arizona Digestive Health Sun City, Arizona, United States
  • Adobe Clinical Research LLC Tucson, Arizona, United States
  • Arkansas Gastroenterology, P.A. North Little Rock, Arkansas, United States
  • Anaheim Clinical Trials Anaheim, California, United States
View all 372 locations
View Trial Details
Completed

Combination Corticosteroids+5-aminosalicylic Acids Compared to Corticosteroids Alone (for Ulcerative Colitis).

NCT02665845

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • Chu Saint Etienne Saint-Etienne, France
  • Department of Gastroenterology Venizeleio General Hospital, Leoforos Knosou Heraklion, Greece
  • Sheba Medical Center Tel Litwinsky, Ramat-Gan, Israel
  • Università di Roma Sapienza Rome, Italy
View Trial Details
Completed

A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors

NCT02165215

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +5 more
Locations
  • University of California, Irvine Medical Center Orange, California, United States
  • Clinical Applications Laboratories, Inc. San Diego, California, United States
  • University of California at San Francisco San Francisco, California, United States
  • Ventura Clinical Trials Ventura, California, United States
View all 104 locations
View Trial Details
Completed

A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors

NCT02100696

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California San Diego Medical Center La Jolla, California, United States
  • Clinical Applications Laboratories, Inc. San Diego, California, United States
  • Precision Research Institute, LLC San Diego, California, United States
View all 184 locations
View Trial Details
Completed

A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors

NCT02163759

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • Rocky Mountain Gastroenterology Associates, P.L.L.C.; Gastroenterology Lakewood, Colorado, United States
  • Center for Advanced Gastroenterology Maitland, Florida, United States
  • Gastroenterology Group of Naples Naples, Florida, United States
  • Gastroenterology Associates of Central Georgia Macon, Georgia, United States
View all 88 locations
View Trial Details
Completed

A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors

NCT02171429

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • Center For Digestive Health Orlando, Florida, United States
  • Internal Medicine Specialists Orlando, Florida, United States
  • Cotton-O'Neil Clinical Research Center, Digestive Health Topeka, Kansas, United States
  • Great Lakes Gastroenterology Research, LLC Mentor, Ohio, United States
View all 90 locations
View Trial Details

Related conditions